CellFE
Regenerative Medicine · Cell & Gene Therapy
Facts
as of Nov 18, 2026We transform the way cell therapies are manufactured to enable affordable advanced treatments for all.
- Headquarters
- Hayward, United States
- Official records
- Wikidata Q141670213
- Website
- cellfebiotech.com
These are the key facts about CellFE on Alion as of Nov 18, 2026. CellFE is headquartered in Hayward, United States. It has raised $26.8M in 2 funding rounds. The latest round is Series A of $22M, announced in 2023.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Footprint
Hiring in 1 city in 1 country.
1Cities
1Countries
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Hayward United States | Headquarters | 0 |
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$26.8MTotal raised
$2.9MPublic grants5 public grants
GrantLatest round
7Rounds and grants
Money by yearUSD, rounds and grants
Sources: funding announcements, grant and company registers
Milestones
Sep 1, 2025
Won a grant $314k · CORDIS
May 13, 2025
Jan 22, 2025
Jan 9, 2025
Sep 27, 2023
Raised a round Series A $22M
May 9, 2023
Dec 2018
Website went live first capture in the Wayback Machine
Each milestone is dated by its source: registers, filings, the press
Newsroom
May 13, 20252025
Blog
CellFE and Made Scientific announce a strategic collaboration to generate pilot data on the CellFE High Volume Cyva System. The post CellFE and Made Scientific Announce Strategic…
Apr 30, 20252025
Blog
CellFE, a leader in non-viral gene editing technology, announces a strategic collaboration with the Harbottle Lab at German Cancer Research Center (DKFZ) and its spin-out company…
Mar 4, 20252025
Blog
CellFE releases a cGMP-compatible workflow to support highly efficient gene editing of iPSCs via a non-viral approach for cell therapy manufacturing. The post Application Note: E…
Jan 22, 20252025
News · YahooFinance
CellFE, a leader in non-viral gene editing technology, today announced the launch of its highly anticipated CellFE T-Rest ("Resting T Cell Kit"), a first-in-class cell manufactur…
Jan 17, 20252025
Blog
In the rapidly evolving field of cellular engineering, achieving complex gene edits with high efficiency and minimal workflow disruption remains a significant challenge. The post…
Jan 9, 20252025
Press release · marketwatch.com
Sources: the outlets named on each headline, each story once
